GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · BSE Equity Only

BSE Exchange Filings, Explained Simply

AI-powered plain-English analysis of every important BSE announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Strictly sourced from BSE exchange announcements (equity segment only). We show only material, important filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India exchange announcements. More categories will be added over time.
Krsnaa Diagnostics Ltd
Krsnaa Diagnostics board overhaul: 2 new independent directors, CFO interim appointment
BOARD ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 17 Apr 2026, 04:57 PM IST  ·  BSE ID: dcd352f3-ebae-4213-80a9-abc73d037ac0
View Original BSE Filing (PDF)
💡
In Simple Terms
Krsnaa Diagnostics replaced three retiring board members with two new independent directors and appointed an interim finance chief.
🤖 AI Summary
  • Board approved two new independent directors effective April 25, 2026 — two-year terms each
  • Raju Venkatraman (DIN: 00632071) and Lilian Jessie Paul (DIN: 02864506) appointed as Additional Directors
  • Chetan Desai reappointed as independent director for five-year term from April 25, 2026 to April 24, 2031
  • Chandra Prakash Singh appointed Interim CFO effective April 17, 2026 pending permanent appointment
  • Three directors' tenures conclude: Pallavi Bhatevara, Rajiva Ranjan Verma, Chhaya Palrecha by April 25, 2026
🔢 Key Numbers — exact figures from BSE filing, not rounded
Raju Venkatraman appointment term
2 consecutive years (April 25, 2026 to April 24, 2028)
Lilian Jessie Paul appointment term
2 consecutive years (April 25, 2026 to April 24, 2028)
Chetan Desai reappointment term
5 consecutive years (April 25, 2026 to April 24, 2031)
Interim CFO effective date
April 17, 2026
🏢 How This Affects the Company
⚙️
Operational Impact
Board composition shifts from three departing directors to two new independent directors plus reappointed director. Interim CFO appointment indicates planned replacement of prior finance head.
⚠️
Risk Impact
Interim CFO status suggests transition period in financial management until permanent appointment. New director appointments subject to shareholder postal ballot approval.
👥 What This Means For Shareholders
✅
Action Required
Shareholders must vote on postal ballot to ratify board appointments and CFO designation within specified timeframe.
👤
Who Is Affected
All shareholders entitled to vote in postal ballot for director appointments and CFO designation as per SEBI LODR regulations.
🔍
Management Signal
Board prioritizes independent director majority and governance strengthening; CFO interim status indicates planned replacement process underway.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Postal ballot outcome — confirm shareholder approval of director appointments within 30 days
Permanent CFO appointment announcement — track replacement timeline and candidate announcement
Next board meeting minutes — verify completion of onboarding for new independent directors
MEDIUM RISK Interim CFO role creates financial management transition uncertainty. Three simultaneous director departures and pending shareholder approval pose execution risk.
💡 Investor Takeaway
Board restructuring approved April 17 brings two independent directors for two-year terms and reappoints Chetan Desai for five years from April 25, 2026. Interim CFO appointment pending permanent hire. All changes subject to postal ballot approval. Three departing directors conclude tenure by April 25, 2026.
⚖️ Strengths & Concerns

✅ Positives

  • New independent directors bring entrepreneurial, operational, and governance experience per Board statement
  • Chetan Desai continuity as five-year reappointed director provides stable governance leadership

⚠️ Concerns

  • Three directors departing simultaneously creates governance transition; permanent CFO role unfilled
  • All appointments pending postal ballot approval — execution contingent on shareholder consent
⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.